- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Sleep Cycle Q3 2026 slides: B2B hits 20%, margins rise amid sales drop | 1 | Investing.com | ||
| Fr | Sleep Cycle AB Q3 Income Declines | 1 | RTTNews | ||
| Fr | Sleep Cycle AB: Sleep Cycle Interim Report July - September 2026: Ready for the next chapter | 110 | GlobeNewswire (Europe) | The third quarter in summary (July - September 2026)Net sales amounted to tSEK 50,863 (61,523) and decreased by 17.3% (6.6%). Currency-adjusted net sales growth amounted to -12.4% (-4.7%). Net sales... ► Artikel lesen | |
| 09.10. | Sleep Cycle AB: Sleep Cycle proposes to acquire Audiowell through a new issue of shares against non-cash consideration | 581 | GlobeNewswire (Europe) | The Board of Directors[1] of Sleep Cycle AB (publ) ("Sleep Cycle" or the "Company") announces today a clearer strategic focus on the wellness market by proposing that an extraordinary general meeting... ► Artikel lesen | |
| SLEEP CYCLE Aktie jetzt für 0€ handeln | |||||
| 22.09. | Sleep Cycle AB: Changes to Sleep Cycle's management team | 207 | GlobeNewswire (Europe) | Sleep Cycle AB (publ) announces that Peter Alsterberg, Chief Commercial Officer, is leaving the company and responsibility for the company's partnerships transfers to the Chief Product Officer.Peter... ► Artikel lesen | |
| 17.09. | Sleep Cycle AB: Sleep Cycle introduces a new way of working and intends to streamline the organisation - savings of approximately SEK 35 million on an annual basis | 333 | GlobeNewswire (Europe) | Sleep Cycle, the leading AI-driven sleep technology company, intends to implement a number of measures to streamline the organisation and move to a more AI-driven way of working, with fewer decision-making... ► Artikel lesen | |
| 11.09. | Sleep Cycle AB: Sleep Cycle Accelerates European Launch of Sleep Apnea Risk Detection While Preserving Pathway to US Regulatory Clearance | 354 | GlobeNewswire (Europe) | Class I CE marking provides an earlier route to market in Europe, enabling Sleep Cycle to establish real-world adoption and partner value while maintaining its ambition for FDA clearance in the United... ► Artikel lesen | |
| 04.09. | Sleep Cycle AB: Sleep Cycle's sleep analysis moves inside the product as partner Moera launches temperature-regulating mattress toppers | 514 | GlobeNewswire (Europe) | Moera is the global IoT and Smart Home partner behind the multi-year licensing agreement Sleep Cycle announced in December 2025, and these temperature-regulating mattress toppers are the first products... ► Artikel lesen | |
| 27.08. | Sleep Cycle AB: Sleep Cycle appoints Mikael Kågebäck as acting CEO | 342 | GlobeNewswire (Europe) | The Board of Directors of Sleep Cycle AB (publ) ("Sleep Cycle") has appointed Mikael Kågebäck, currently Chief Technology and Product Officer (CTPO) of the company, as acting CEO, effective as of 27... ► Artikel lesen | |
| 26.08. | Sleep Cycle Q2 2026 slides: B2B pivot gains traction amid consumer pressure | 2 | Investing.com | ||
| 26.08. | Earnings Call: Umsatz von Sleep Cycle bricht in Q2 2026 ein, Aktie gibt um 2,4 % nach | 1 | Investing.com Deutsch | ||
| 26.08. | Sleep Cycle AB: Sleep Cycle Interim Report April - June 2026: A greater opportunity takes shape | 379 | GlobeNewswire (Europe) | The second quarter in summary (April-June 2026)
Net sales amounted to tSEK 49,904 (63,559) and decreased by 21.5% (2.9%). Currency-adjusted net sales growth amounted to -15.4% (-0.6%). Net sales from... ► Artikel lesen | |
| 05.08. | Sleep Cycle AB: Resolutions at Sleep Cycle's Extraordinary General Meeting 2026 | 273 | GlobeNewswire (Europe) | At the Extraordinary General Meeting (the "EGM") of Sleep Cycle AB (publ) on 5 August 2026, the following was resolved.
Number of Board membersThe EGM resolved that the number of members of the Board... ► Artikel lesen | |
| 23.07. | Sleep Cycle AB: Sleep Cycle signs tech licensing agreement with Ant Group | 2.740 | GlobeNewswire (Europe) | Sleep Cycle, a leader in AI-powered sleep technology, today announced that it has signed an SDK licensing agreement with Ant Group, one of China's most prominent technology companies and the operator... ► Artikel lesen | |
| 03.07. | Sleep Cycle AB: Sleep Cycle signs commercial SDK licensing agreement with Ultrahuman following successful pilot | 259 | GlobeNewswire (Europe) | Sleep Cycle, the leading AI-powered sleep technology company, today announced that it has signed a commercial licensing agreement with Ultrahuman, a global health and wearable technology company. The... ► Artikel lesen | |
| 22.05. | Sleep Cycle AB: The Board of Directors of Sleep Cycle unanimously recommends the shareholders not to accept the public cash offer by Altor | 425 | GlobeNewswire (Europe) | Following an overall assessment, the Board is of the opinion that the Offer does not adequately reflect the value of Sleep Cycle, particularly in light of a strong cash generating subscription-based... ► Artikel lesen | |
| 11.05. | Sleep Cycle AB (publ) receives observation status | 568 | GlobeNewswire | Today, May 11, 2026, Snark BidCo AB, a company controlled by Altor Fund V (No.1) AB and Altor Fund V (No.2) AB, disclosed a public takeover offer to the shareholders of Sleep Cycle AB (publ) (the... ► Artikel lesen | |
| 11.05. | Sleep Cycle AB: The Board of Directors evaluates the offer from Altor | 481 | GlobeNewswire (Europe) | Snark BidCo AB[1] (the "Offeror"), a company controlled by Altor Fund V (No.1) AB and Altor Fund V (No.2) AB, today announced a public takeover offer to the shareholders of Sleep Cycle AB (publ) ("Sleep... ► Artikel lesen | |
| 29.04. | Sleep Cycle AB: Sleep Cycle Interim Report January - March 2026: Strategic expansion into new growth areas | 389 | GlobeNewswire (Europe) | Sleep Cycle is accelerating its transformation from sleep app to platform within sleep and digital health. In the first quarter of 2026, B2B revenue grew by 42 percent and accounted for 14.5% of total... ► Artikel lesen | |
| 14.04. | Dividendenbekanntmachungen (14.04.2026) | 7.397 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABC ARBITRAGE SA FR0004040608 - 0,1 EUR AKVA GROUP ASA NO0003097503 1 NOK 0,09 EUR AMERICAN TOWER CORPORATION US03027X1000 1,79... ► Artikel lesen |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SAP | 214,40 | -0,44 % | Nasdaq nach dem Absturz: Tesla, Meta & SAP müssen jetzt liefern! | ||
| NEXTPOWER | 78,87 | -0,03 % | Nextracker: Warum der Marktführer bei Solargeneratoren jetzt mehr ist als ein Tracker-Spezialist | Nextracker schärft sein Profil als integrierter Anbieter für Solar-Infrastruktur und treibt eine strategische Ausweitung über das Kerngeschäft mit Solarmodul-Trackern hinaus voran. Der von Seeking Alpha... ► Artikel lesen | |
| MICROSOFT | 468,70 | +0,04 % | Tech-Konzerne unter Druck: KI unterm Weihnachtsbaum: Geht diese Rechnung für Apple und Co. auf? | © Foto: - - Apple/dpaBig Tech bringen neue KI-Geräte auf den Markt. Doch hohe Preise, Inflation und skeptische Verbraucher machen das Weihnachtsgeschäft zum entscheidenden Test Enthaltene Werte: US0231351067... ► Artikel lesen | |
| SERVICETITAN | 87,05 | -0,01 % | Aktien New York: Ölpreis belastet Dow weiter - Meta-Rally an Nasdaq | NEW YORK (dpa-AFX) - Die US-Aktienmärkte lassen am Mittwoch weiter Federn. Vor allem die Standardwerte leiden unter weiter gestiegenen Ölpreisen, die bei den Anlegern die Inflations- und Zinssorgen... ► Artikel lesen | |
| NEMETSCHEK | 75,70 | +0,80 % | JPMORGAN stuft NEMETSCHEK AG auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - JPMorgan hat Nemetschek mit einem Kursziel von 110 Euro auf "Overweight" belassen. Die Aktien stehen zudem auf der "Analyst Focus List" der US-Bank. Die Quartalszahlen... ► Artikel lesen | |
| DUOLINGO | 143,00 | -0,03 % | DA Davidson erhöht Kursziel für Duolingo angesichts dynamischer DAU-Trends | ||
| KLAVIYO | 21,125 | +0,05 % | After Braze, Could Klaviyo Be Big Tech's Next Billion-Dollar Bet? | ||
| HINGE HEALTH | 111,40 | 0,00 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen | |
| CLEARONE | 3,250 | 0,00 % | Morning Market Movers: ClearOne, ThredUp, SiTime, Insmed See Big Swings | BEIJING (dpa-AFX) - At 8:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ATOSS SOFTWARE | 87,30 | -8,97 % | Steady quarter ahead, margin upside in reach: ATOSS releases preliminary Q3 on Friday: we expect sales ... | ATOSS will release preliminary Q3 figures on Friday. We expect another strong quarter, which should make the margin guidance look conservative. In detail: We expect Q3 sales of € 53.3m (+12.9% yoy,... ► Artikel lesen | |
| BIO-KEY INTERNATIONAL | 3,390 | 0,00 % | BIO-key sichert sich Regierungsauftrag für Biometrie im Nahen Osten | ||
| DOXIMITY | 33,380 | 0,00 % | Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask | Physicians can see Doximity Ask's AI-generated answer in addition to expert-written content from UpToDate
Doximity (NYSE: DOCS), the leading digital platform for U.S. medical professionals, and... ► Artikel lesen | |
| PALANTIR TECHNOLOGIES | 174,74 | -0,58 % | Palantir-Aktie mit -13% - nächstes Ziel 139 US$? | Die Palantir-Aktie wird nach ihrem neuen Rekordhoch von heftigen Gewinnmitnahmen erfasst. Am Freitag brach der KI-Titel um -7,22% auf 186,03 US$ ein. Damit steht der Kurs unmittelbar an einer wichtigen... ► Artikel lesen | |
| TEAMVIEWER | 7,430 | -0,47 % | TeamViewer mit SONDERMELDUNG: Folgt jetzt der nächste Kursrutsch? - Jetzt unbedingt lesen! | ||
| TRADE DESK | 11,580 | +0,26 % | Ihre wichtigsten Termine: Alle Blicke auf: Bawag, BHP, Jefferies, Trade Desk und DSM-Firmenich | © Foto: Li Bo/XinHua/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag Enthaltene Werte: AU000000BHP4... ► Artikel lesen |
Das Unternehmen SLEEP CYCLE AB kann der Branche Software zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,73 % bei einem Aktienkurs von 2,070 Euro. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,00 Euro errechnet sich eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SLEEP CYCLE AB finden Sie auf Wallstreet Online.